The company’s Government Policy and Reimbursement team works with lawmakers, governments and policymakers worldwide to support patient access to the company’s lifesaving therapies, improve the regulatory environment and reimbursement structure for Baxter’s therapies, increase understanding of the benefits of those therapies and address barriers to care.